Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Nov 27, 2021 12:31pm
186 Views
Post# 34172223

RE:RE:RE:RE:Timing

RE:RE:RE:RE:Timing
menoalittle wrote:

Furthermore, considering that "natural immunity" (after recovery from an infection) is already proving to produce more effecitive and far longer lasting antibody protection than the mRNA vaccines themselves, this approach Theralase is taking makes a whole lot of sense. 

What appears to be quite insane however (at least, to anyone with half a brain, it seems), is the fact that there is still no recognition or acknowledgement of the effectiveness of natural immunity.  But, this is undoubtedly due to the prescribed "agenda" those in political power have in play. 



The "prescribed agenda" you refer to presumably is "the money trail" -- isn't it always? How many with natural immunity? 40M, 50M, 100M? Would sure cut down on vaccine revenues. Amazing that it is not even part of the conversation -- ignoring things these days appears to be quite effective.
<< Previous
Bullboard Posts
Next >>